Search
Xilio Therapeutics Inc
XLOAdd to Watchlist
9.070USD
-0.150-1.63%
Market hours （ET）Quotes delayed by 15 min
52.45MMarket Cap
LossP/E TTM
Xilio Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-01The current valuation score of Xilio Therapeutics Inc is 9.78, ranking 12 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.16, which is -19.09% below the recent high of -0.13 and -7807.45% above the recent low of -12.84.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.